Conmed Corp (NYSE:CNMD)
$ 74.76 -0.88 (-1.16%) Market Cap: 2.31 Bil Enterprise Value: 3.24 Bil PE Ratio: 17.76 PB Ratio: 2.47 GF Score: 75/100

Conmed Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 07:30PM GMT
Release Date Price: $84.56 (-1.57%)
Mason E. Austen
Morgan Stanley, Research Division - Research Associate

My name is Mason Austen, associate on the medical device research team here at Morgan Stanley. I'm pleased to welcome CONMED here with us today as part of our virtual Healthcare Conference. From the company, we have Curt Hartman, President and CEO; Todd Garner, Executive Vice President and CFO.

Before we get started, just a quick disclaimer. Please note this webcast is for Morgan Stanley clients and employees only. This webcast is not for members of the press. If you're a member of the press, please disconnect and reach out separately. For additional details on disclosures, please visit morganstanley.com/researchdisclosures.

So with that, Curt, Todd, thank you both for being here today. And we can go ahead and jump right in, if you want to skip the preamble here. Soâ¦

Curt R. Hartman
CONMED Corporation - Chairman of the Board, CEO & President

[Yes].

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot